share_log

君聖泰醫藥-B：自願性公告業務發展情況更新

HIGHTIDE-B: VOLUNTARY ANNOUNCEMENTBUSINESS UPDATE

Hong Kong Stock Exchange ·  Jun 28 18:38
Summary by Futu AI
君聖泰醫藥-B（2511）於2024年6月28日宣布，根據2024年1月19日的計劃，將業務擴展至中國河北省滄州渤海新區南大港產業園區。此舉旨在利用當地優惠政策，建立原材料生產基地，提升供應能力，並為其核心產品在中國市場建立可靠的戰略合作夥伴關係。公司董事會認為此業務擴展方案將符合公司及股東整體利益。目前，公司正在與當地政府及相關方積極溝通，將按照規定適時發佈進一步公告。投資者在交易股份時應謹慎。
君聖泰醫藥-B（2511）於2024年6月28日宣布，根據2024年1月19日的計劃，將業務擴展至中國河北省滄州渤海新區南大港產業園區。此舉旨在利用當地優惠政策，建立原材料生產基地，提升供應能力，並為其核心產品在中國市場建立可靠的戰略合作夥伴關係。公司董事會認為此業務擴展方案將符合公司及股東整體利益。目前，公司正在與當地政府及相關方積極溝通，將按照規定適時發佈進一步公告。投資者在交易股份時應謹慎。
On June 28, 2024, K&S Pharma-B (2511) announced plans to expand its business to Nandagang Industrial Park in Bohai New Area, Cangzhou, Hebei Province, China, according to a plan made on January 19, 2024. The move aims to take advantage of local preferential policies, establish raw material production bases, enhance supply capabilities, and establish reliable strategic partnerships for its core products in the Chinese market. The board of directors of the company believes that this business expansion plan will be in line with the overall interests of the company and shareholders. Currently, the company is actively communicating with the local government and relevant parties and will issue further announcements in accordance with regulations. Investors should be cautious when trading shares.
On June 28, 2024, K&S Pharma-B (2511) announced plans to expand its business to Nandagang Industrial Park in Bohai New Area, Cangzhou, Hebei Province, China, according to a plan made on January 19, 2024. The move aims to take advantage of local preferential policies, establish raw material production bases, enhance supply capabilities, and establish reliable strategic partnerships for its core products in the Chinese market. The board of directors of the company believes that this business expansion plan will be in line with the overall interests of the company and shareholders. Currently, the company is actively communicating with the local government and relevant parties and will issue further announcements in accordance with regulations. Investors should be cautious when trading shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.